TOCILIZUMAB AS A POTENTIAL NOVEL THERAPY IN PATIENTS DIAGNOSED WITH ADAMANTINOMATOUS CRANIOPHARYNGIOMA

被引:0
|
作者
Grob, Sydney [1 ,2 ,3 ]
Donson, Andrew [1 ,2 ,3 ]
Prince, Eric [1 ,4 ]
Vijmasi, Trinka [1 ,4 ]
Foreman, Nicholas [1 ,2 ,3 ]
Dahl, Nathan [1 ,2 ,3 ]
Vibhakar, Rajeev [1 ,2 ,3 ]
Mirsky, David [1 ,5 ]
Hankinson, Todd [1 ,4 ]
Levy, Jean Mulcahy [1 ,2 ,3 ]
机构
[1] Univ Colorado, Aurora, CO USA
[2] Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA
[3] Morgan Adams Fdn Pediat Brain Tumor Res Program, Aurora, CO USA
[4] Childrens Hosp Colorado, Dept Neurosurg, Aurora, CO USA
[5] Childrens Hosp Colorado, Dept Radiol, Aurora, CO USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
THER-33
引用
收藏
页码:120 / 121
页数:2
相关论文
共 50 条
  • [1] Recurrent adamantinomatous craniopharyngioma stabilized with tocilizumab and bevacizumab: illustrative case
    Webb, Lauren M.
    Okuno, Scott H.
    Ransom, Ryan C.
    Van Gompel, Jamie J.
    Humes, Allison L.
    Sarkaria, Jann N.
    Ruff, Michael W.
    JOURNAL OF NEUROSURGERY-CASE LESSONS, 2025, 9 (02):
  • [2] A Novel Immune Classification for Predicting Immunotherapy Responsiveness in Patients With Adamantinomatous Craniopharyngioma
    Yuan, Feng
    Cai, Xiangming
    Zhu, Junhao
    Yuan, Lei
    Wang, Yingshuai
    Tang, Chao
    Cong, Zixiang
    Ma, Chiyuan
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [3] Hub genes for early diagnosis and therapy of adamantinomatous craniopharyngioma
    Zou, Yang-Fan
    Zhang, Shu-Yuan
    Li, Li-Weng
    Jing, Kai
    Xia, Liang
    Sun, Cai-Xing
    Wu, Bin
    MEDICINE, 2022, 101 (37) : E30278
  • [4] Adamantinomatous craniopharyngioma in the molecular age and the potential of targeted therapies: a review
    Whelan, Ros
    Hengartner, Astrid
    Folzenlogen, Zach
    Prince, Eric
    Hankinson, Todd C.
    CHILDS NERVOUS SYSTEM, 2020, 36 (08) : 1635 - 1642
  • [5] PHASE 0 AND FEASIBILITY SINGLE-INSTITUTION CLINICAL TRIAL OF INTRAVENOUS TOCILIZUMAB FOR ADAMANTINOMATOUS CRANIOPHARYNGIOMA
    Dorris, Kathleen
    Mettetal, Ashley
    Hemenway, Molly
    Winzent-Oonk, Shelby
    Dahl, Nathan
    Levy, Jean Mulcahy
    Prince, Eric
    McWilliams, Jennifer
    Jordan, Kimberly R.
    Mirsky, David
    Hoffman, Lindsey
    Hankinson, Todd
    NEURO-ONCOLOGY, 2024, 26
  • [6] Adamantinomatous craniopharyngioma in the molecular age and the potential of targeted therapies: a review
    Ros Whelan
    Astrid Hengartner
    Zach Folzenlogen
    Eric Prince
    Todd C. Hankinson
    Child's Nervous System, 2020, 36 : 1635 - 1642
  • [7] PHASE 0 AND FEASIBILITY SINGLE-INSTITUTION CLINICAL TRIAL OF INTRAVENOUS TOCILIZUMAB FOR ADAMANTINOMATOUS CRANIOPHARYNGIOMA
    Dorris, Kathleen
    Mettetal, Ashley
    Dahl, Nathan
    Hemenway, Molly
    Winzent-Oonk, Shelby
    Prince, Eric
    Vijmasi, Trinka
    McWilliams, Jennifer
    Jordan, Kimberly
    Mirsky, David
    Hoffman, Lindsey
    Hankinson, Todd
    NEURO-ONCOLOGY, 2022, 24 : 17 - 17
  • [8] Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma
    Andoniadou, Cynthia L.
    Gaston-Massuet, Carles
    Reddy, Rukmini
    Schneider, Ralph P.
    Blasco, Maria A.
    Le Tissier, Paul
    Jacques, Thomas S.
    Pevny, Larysa H.
    Dattani, Mehul T.
    Martinez-Barbera, Juan Pedro
    ACTA NEUROPATHOLOGICA, 2012, 124 (02) : 259 - 271
  • [9] Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma
    Cynthia L. Andoniadou
    Carles Gaston-Massuet
    Rukmini Reddy
    Ralph P. Schneider
    Maria A. Blasco
    Paul Le Tissier
    Thomas S. Jacques
    Larysa H. Pevny
    Mehul T. Dattani
    Juan Pedro Martinez-Barbera
    Acta Neuropathologica, 2012, 124 : 259 - 271
  • [10] Identification of the MAPK/ERK Pathway as a Novel Therapeutic Target in Adamantinomatous Craniopharyngioma
    Guiho, Romain
    Apps, John R.
    Hong, Ying
    Hargrave, Darren
    Brogan, Paul
    Jacques, Thomas S.
    Martinez-Barbera, Juan Pedro
    HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 58 - 59